The purpose of this paper was to determine the effects of freeze-thaw cycling and diagnosis on serum levels of U6, microRNA (miR)-16, and miR-24.
U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Xiang M, Zeng Y, Yang R, Xu H, Chen Z, Zhong J, Xie H, Xu Y, Zeng X
Purpose
Conclusion
While U6 cycle threshold (CT) values increased with freeze-thaw cycling, miR-16 and miR-24 CT values remained consistent through 4 freeze-thaw cycles. U6 levels were affected by diagnosis and were highly variable, but miR-16 levels were very stable.
Studies (1)
Purpose
The purpose of this study was to determine the effects of freeze-thaw cycling and diagnosis on serum levels of U6, miR-16, and miR-24. Serum from 80 cancer patients (20 each of gastric, breast, colorectal and nasopharyngeal cancers) and from 30 healthy volunteers was stored frozen at -80°C. RNA was isolated using the mirVana PARIS kit, and miRNA was quantified using TaqMan low density arrays (TLDA). The number of serum specimens included in freeze-thaw cycling experiments was unspecified.
Summary of Findings
While U6 CT values increased with freeze-thaw cycling of serum, miR-16 and miR-24 CT values remained consistent through 4 freeze-thaw cycles. The expression of U6 was higher in serum from patients with nasopharyngeal carcinoma than in control patients, and when U6 levels were investigated in 30 healthy individuals and 80 cancer patients, a high degree of variability was observed. In contrast, miR-16 levels were very stable.
Biospecimens
FluidSerumPreservation Types
FrozenDiagnoses
NeoplasticCarcinomaNormalPlatforms
RNALow density arrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition HealthyNasopharyngeal carcinomaStorage Freeze/thaw cycling 1 cycle2 cycles3 cycles4 cyclesLow density array Specific Targeted nucleic acid U6miR-16miR-24